Thalidomide Use in the US
- 1 January 2006
- journal article
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 29 (4), 321-329
- https://doi.org/10.2165/00002018-200629040-00003
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- ACOG committee opinion #278: avoiding inappropriate clinical decisions based on false-positive human chorionic gonadotropin test resultsObstetrics & Gynecology, 2002
- False-positive serum human chorionic gonadotropin results: Causes, characteristics, and recognitionAmerican Journal of Obstetrics and Gynecology, 2002
- Thalomid?? (Thalidomide) CapsulesDrug Safety, 2001
- False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrationsThe Lancet, 2000
- S.T.E.P.S.™: A comprehensive program for controlling and monitoring access to thalidomideClinical Therapeutics, 1999
- Gestational trophoblastic diseaseCancer, 1995
- Measuring human chorionic gonadotropin for detection of early pregnancy lossReproductive Toxicology, 1988
- Further observations on serial human chorionic gonadotropin patterns in ectopic pregnancies and spontaneous abortionsFertility and Sterility, 1988
- Thalidomide embryopathy.1962
- Thalidomide EmbryopathyArchives of environmental health, 1962